DiaPharma
Private Company
Funding information not available
Overview
DiaPharma is a long-established, private company operating as a specialty distributor and provider of diagnostic and research assay kits, with a core focus on hemostasis (bleeding/clotting disorders), liver disease biomarkers, and NETosis research. Its business model centers on distributing products from third-party manufacturers while adding significant value through deep technical support and custom order capabilities. The company serves clinical and research laboratories, leveraging a portfolio of biomarkers and instruments to address niche areas within diagnostics and translational research.
Technology Platform
Value-added distributor and scientific support platform for specialty diagnostic assays, reagents, antibodies, and instruments in hemostasis, liver disease, and cell death research. Leverages deep technical expertise rather than a proprietary technology.
Opportunities
Risk Factors
Competitive Landscape
DiaPharma competes in niche segments against other specialty diagnostics distributors (e.g., Aniara Diagnostica, Haematologic Technologies) and the specialized divisions of large, broad-line diagnostic companies (e.g., Siemens Healthineers, Werfen). Its primary competitive advantage is its focused expertise and high-touch customer support, rather than product breadth or low cost.